Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Closure of Trading Window

 This is to inform you that, in accordance with the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 read with AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the Equity Shares of the Company will be closed from March 16, 2024 and the same shall reopen after 48 hours from the declaration of Audited Financial Results of the Company for the quarter and year ending March 31, 2024.
13-03-2024
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We are enclosing herewith the certificate dated March 6, 2024 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
12-03-2024
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) and other applicable regulations of SEBI (LODR) Regulations, 2015, we would like to inform you that the Registrar and Share Transfer Agents of the Company, Integrated Registry Management Services Private Limited have informed the Company on the attached request for Loss of Share Certificate from the legal representative of the claimant.
11-03-2024

AstraZeneca Pharma India, Mankind Pharma Ink Pact To Distribute Asthma Medicine

 Symbicort is owned by AstraZeneca, which will retain the intellectual property rights.
11-03-2024
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Please find enclosed the copy of press release in connection with a Distribution and Promotion Agreement entered into by the Company with Mankind Pharma Limited for the distribution of budesonide and formoterol fumarate dihydrate (brand name Symbicort) in India.
11-03-2024
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find the enclosed Newspaper Publication in relation to the Postal Ballot Notice for your reference.
06-03-2024
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 We are enclosing herewith the Postal Ballot Notice dated February 8, 2024 being sent to the members of the Company to their registered email address, seeking approval of the members for the special business as set out therein. The Notice is being sent to the members whose names appear in the Register of Members/ Record of Depositories as on the cut-off date being Friday, March 1, 2024. The e-voting period commences on Thursday, March 7, 2024 (9:00 am IST) and ends on Friday, April 5, 2024 (5:00 pm IST).
06-03-2024
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby inform that an interaction with investor(s) is scheduled to be held as per the details attached.
04-03-2024
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')

 Please find the enclosed letter of the Company in relation to the captioned subject for your reference.
23-02-2024
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) and other applicable regulations of SEBI (LODR) Regulations, 2015, we would like to inform you that the Registrar and Share Transfer Agents of the Company, Integrated Registry Management Services Private Limited have informed the Company on the enclosed request for Loss of Share Certificate from the claimant. Further, subject to the completion of required formalities by the shareholder, the Company will issue Letter of Confirmation thereof.
22-02-2024
Next Page
Close

Let's Open Free Demat Account